FDA July 2026 Peptide Meeting: What Patients Need to Know About Access, Approval, and Safety Meto blog Peptide Compounding Pharmacy Physician Prescribed Peptides Massey Drugs FDA Adds Several Peptides to Category 2 Bulks List, Restricting Them From Compounding Restore Health Consulting Liraglutide Dosage Chart Olympia Pharmaceuticals FDA has removed certain bulk drug substances that were placed on the category two list and has announced it will consult the Pharmacy Compounding Advisory Committee (PCAC) for potential future inclusion of When will the FDA reclassify BPC 157 to Category 1? Odds & Predictions